Shin Nippon Biomedical Laboratories Ltd
F:YB3
Wall Street
Price Targets
YB3 Price Targets Summary
Shin Nippon Biomedical Laboratories Ltd
According to Wall Street analysts, the average 1-year price target for YB3 is 14.15 EUR with a low forecast of 9.63 EUR and a high forecast of 19.13 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is YB3's stock price target?
Price Target
14.15
EUR
According to Wall Street analysts, the average 1-year price target for YB3 is 14.15 EUR with a low forecast of 9.63 EUR and a high forecast of 19.13 EUR.
What is Shin Nippon Biomedical Laboratories Ltd's Revenue forecast?
Projected CAGR
7%
For the last 13 years the compound annual growth rate for Shin Nippon Biomedical Laboratories Ltd's revenue is 6%. The projected CAGR for the next 3 years is 7%.
What is Shin Nippon Biomedical Laboratories Ltd's Operating Income forecast?
Projected CAGR
4 577%
The compound annual growth rate of Shin Nippon Biomedical Laboratories Ltd's operating income for the next 2 years is 4 577%.
What is Shin Nippon Biomedical Laboratories Ltd's Net Income forecast?
Projected CAGR
4%
The compound annual growth rate of Shin Nippon Biomedical Laboratories Ltd's net income for the next 3 years is 4%.
